The Korea Medical Institute said Tuesday it has signed a memorandum of understanding with US-based Guardant Health to collaborate on liquid biopsy-based precision cancer screening.
The agreement was signed March 5 at the KMI F
Continue Reading on The Korea Herald
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.